The molecular nature of tissue-specific gene regulation by androgens has not been well defined, partly as a result of the variable expression and incomplete regulation of currently available gene models. We have therefore aimed to establish more informative models by identifying alternative genes whose expression is tightly and coordinately regulated by androgens. Female C57BL/6 mice were dosed with dihydrotestosterone-or sham-treated for 8 days, after which kidneys were removed and complementary DNA (cDNA) prepared. We then applied the subtractive hybridization techniques of random arbitrarily primed-PCR and PCR-coupled subtractive hybridization method of cDNA representational difference analysis to the isolated cDNA. In addition to well characterized androgen-regulated genes [e.g. KAP (kidney androgen-regulated protein)], we demonstrate the differential expression of six genes previously not known to be under androgen control. RNA levels of SA, Cytochrome P450 4B1, IL-6ST (interleukin-6 signal transducer), OATP (organic anion transporter), and a newly identified gene, MJAM, were up-regulated by androgen, while 16-␣-hydroxylase was decreased. Expression of these transcripts was inhibited in dihydrotestosterone-treated females by flutamide and in males by castration, confirming their dependence on androgens. Although all the genes demonstrate tissuespecific regulation by androgen, SA showed both kidney specificity and absolute requirement for androgen for its expression. These newly identified androgen-regulated genes will constitute very useful models for studying the nature of tissue-specific gene regulation by androgens. (Endocrinology 139: 688 -695, 1998) 
U
NDERSTANDING the processes by which extracellular stimuli modulate the expression of specific genes in a temporal and/or tissue-specific manner is crucial for unravelling the molecular mechanisms underlying cellular growth, homeostasis, differentiation, and development.
Androgens, as well as other steroid hormones, vitamin D, and thyroid hormones function in different biological programs through the binding of intracellular receptors, which act as ligand-inducible transcription factors on specific DNA elements of target genes (see Refs. 1 and 2 for reviews). The DNA-binding domain of the androgen receptor displays a remarkable amino acid sequence identity with that of glucocorticoids, progesterone, and mineralocorticoid receptors, and all activate the same hormone-response element, which was originally defined as the consensus response element for glucocorticoids (GGTACAnnnTGTTTCT) (2, 3) . The difficulty of understanding how these four different steroids can exert specific actions under physiological conditions has been recently clarified by the demonstration that hormone specificity lies in the ability of nonreceptor factors to distinguish and interact between a set of receptors that recognize a common DNA response element (4, 5) . The arrangement of the hormone-response element within the promoter is critical, since the presence of adjacent hormone-responsive elements and their proximity to binding sites for transcription factors may alter the specificity as well as the magnitude of the hormonal response (6 -9) .
The murine kidney has been extensively used as a model for androgen action because, contrary to their effects in the accessory sex organs of the male reproductive tract, androgens lead only to hypertrophic changes in kidney, with no increase in DNA replication (10) , and testosterone itself is the primary effector of the androgenic response, due to low or nonexistent levels of 5-␣-reductase (11) . The inducibility of genes such as those coding for ␤-GLUC (12, 13) , ornithine decarboxylase (ODC) (14) , alcohol dehydrogenase (ADH) (15) , kidney androgen-regulated protein (KAP) (16) and RP2 (17) , classically used as markers for androgen action in mouse kidney, shows striking variation among different strains and species of mice (10, 18 -20) . Furthermore, they also show differential sensitivity to androgens upon androgen stimulation in identical samples (21) . Although glucocorticoid-response element-like sequences have been found in regulatory regions of all of these genes, detailed characterization of the molecular elements mediating androgenresponsive gene expression in the kidney has proved to be difficult. In addition to the lack of an appropriate androgenresponsive cell culture system for DNA transfection studies, the current gene models available are, in fact, quite different in their kinetics of induction, their capability to respond to other hormonal stimuli (22) , and in the involvement of other hormones in their androgenic response (23, 24) . Therefore, attempts to identify common cis-and trans-elements involved in androgenic regulation of gene expression in mouse kidney have failed.
Since androgen hormone action is promoter-, cell-, ligand-, and species-dependent, we have undertaken a project aimed at identifying novel kidney androgen-regulated genes whose expression is controlled by dihydrotestosterone (DHT) under identical induction conditions and in the same mouse strain. We adopted a combined approach, using both the differential display-like technique of random arbitrarily primed PCR (RAP-PCR) (25, 26) and the PCR-coupled subtractive hybridization method of cDNA representational difference analysis (cDNARDA) (27) . cDNARDA is an effective and sensitive method that has been successfully applied to a number of different problems, including identification of cell line and tissue-specific gene expression (28) ; targets of hormone action; and targets of transcription factor action (29, 30) and developmental gene expression (31, 32) . RAP-PCR permits the detection of lower degrees of regulation than cDNARDA, and up-and down-regulation can be selected in the same assay. Using this complementary approach, we have been able to demonstrate unique differences in gene expression between mouse kidney samples from sham-and DHT-treated C57BL/6 female mice. The isolation and identification of coordinately up-regulated genes in this system have provided new targets of androgen action that will be extremely useful to further define the elements and delineate the mechanisms underlying the generation of an androgenregulated phenotype in mouse kidney.
Materials and Methods

Animals and hormonal treatment
C57BL/6 strain male and female mice were obtained from LETICA S.A. (Barcelona, Spain) at 6 weeks of age. Mice were housed in the animal facilities in covered cages at 22 C with 12-h periods of light and darkness. Pelleted food and tap water were supplied ad libitum.
Male mice were castrated under droperidol and midazolam anesthesia and allowed to recover for 8 days before receiving further treatment.
DHT-and hormone free-containing implants were obtained from Innovative Research of America (IRA, Sarasota, FL) and used as previously described (33) . Androgen-treated animals were treated for a period of 8 days with a DHT dose of 19 g/day and killed by cervical dislocation. When required, 5 mg of the antiandrogen flutamide (2-methyl-N-[4-nitro-3-(trifluoromethyl) phenyl] propanamide) were prepared in 0.4 ml 3:1 (vol/vol) sesame oil/absolute ethanol vehicle and injected sc daily, for a period of 8 days concomitantly with the DHTcontaining pellets.
All 
RNA isolation
Total RNA was extracted from kidneys of DHT-and sham-treated female animals using the guanidinium thiocyanate method (34) . PolyA ϩ selected RNA was isolated using the messenger RNA (mRNA) purification kit (Pharmacia Biotech, Inc., Uppsala, Sweden).
Arbitrarily primed PCR of RNA (RAP-PCR)
Total RNA from kidneys of DHT-or sham-treated female mice was processed as described by Ralph et al. (26) with some modifications.
Briefly, 1 g deoxyribonuclease-treated RNA was denatured at 70 C for 10 min and placed on ice before cDNA synthesis. Oligo(dT) primer (5 m) was used to initiate first-strand cDNA synthesis, using Moloney Murine Leukemia Virus (MoMLV) reverse transcriptase (Promega Corp., Madison, WI), following the protocol previously reported (26) .
Second-strand cDNA was synthesized by arbitrary priming PCR, using the oligos: aT3A, 5Ј-TTGGGTGTGGTCTCT-3Ј; MAYA, 5Ј-CAG-CATTTCTCATCC-3Ј and 3.99R, 5Ј-TTCGGGGGCCAGCTA-3Ј. Different amounts (3 and 6 l) of the first-strand synthesis reaction were mixed with a buffer containing 50 mm KCl, 10 mm Tris, pH 9.0, 0.1% Triton X-100, 1.5 mm MgCl 2 , 0.2 mm each deoxynucleoside triphosphate, 0.1 mCi/ml [␣ 33 P]dATP,1 U Taq polymerase (Perkin Elmer-Cetus, Norwalk, CT) and 1 m of each of the arbitrarily chosen primers, in a final volume of 25 l. The reaction mixtures (one for each arbitrary primer) were subjected to 94 C for 5 min to denature, followed by two low-stringency PCR cycles (94 C for 5 min, 40 C for 5 min, and 72 C for 5 min) and by 40 high-stringency PCR cycles (94 C for 1 min, 60 C for 1 min, and 72 C for 2 min), with a final extension of 72 C for 7 min. Two microliters of each reaction were denatured at 95 C for 5 min, loaded into a 6% acrylamide-8 m urea sequencing gel, and electrophoresed at high voltage until the xylene cyanol dye reached the bottom of the gel. After run, the gel was dried and exposed to Hyperfilm-MP x-ray film (Amersham, Arlington Heights, IL).
Differentially amplified RAP products were excised from the gel, eluted, and reamplified as previously described (26) .
Representational difference analysis of cDNA (cDNARDA)
Double-stranded cDNA was synthesized from 5 g mRNA from kidneys of DHT-(tester) or sham-treated female mice (driver) and cDNARDA was performed as described by Hubank and Schatz (27) . Sequences of the oligonucleotides used to prepare adaptors and for PCR amplification are the same as those described by Hubank and Schatz (27) .
After two rounds of subtraction and amplification, difference products were run in a 1.3% agarose gel and stained with ethidium bromide to visualize bands. After being excised and eluted from the gel, they were cloned and used as probes in Northern blot analysis.
Preparation of clones
RAP differential bands were cloned into the pGEM vector (Promega), and RDA differential products were cloned into the pBluescript II SK ϩ vector (Stratagene, La Jolla, CA). When possible, 10 independently isolated colonies were picked for each RAP and RDA product, and plasmid minipreparations were made using the Wizard System (Promega). Clones were checked for inserts by PCR or by restriction digestion: NcoI and PstI enzymes for RAP products and XbaI and PstI for RDA differential clones (Boehringer-Mannheim, Mannheim, Germany), followed by an agarose gel.
Northern blot analysis
Three micrograms of mRNA were electrophoresed in a 6.5% formaldehyde-1.4% agarose gel, blotted to Hybond N nylon membranes (Amersham), and hybridized with random priming 32 P-labeled cDNA probes (Stratagene) at 42 C in 50% formamide. After hybridization, filters were washed four times at room temperature for 10 min in 2ϫ saline sodium citrate/0.1% SDS, followed by 1 h at 50 C in 0.2ϫ saline sodium citrate/0.1% SDS. The glyceraldehyde-3-phosphate dehydrogenase probe was used as an internal control on each hybridization.
Sequencing and identification of differential products
Sequence analysis of differentially expressed cDNA products was effected with the Sequenase version 2.0 DNA sequencing kit (USB Corp., Cleveland, OH). Resulting sequences were compared with the GenBank and dbEST databases using the BLAST program (35) . Accession web site: http://www.ncbc.nlm.nih.gov/BLAST.
Results
RAP-PCR
Initially, we used the classic androgen-up-regulated genes ␤-glucuronidase (␤-GLUC) and kidney androgen-regulated protein (KAP) as positive controls for treatment efficacy. Probes from these genes were hybridized to mRNA prepared from kidneys of sham and DHT-treated female mice on Northern blots. Androgen-induced expression levels for KAP and ␤-GLUC genes were obtained as expected (36) , confirming that the androgenic treatment of the animals was appropriate (Fig 1A) .
To check whether inbred animals of the same litter were displaying polymorphisms at the mRNA level, unrelated to the hormonal treatment, RAP-PCR was performed on kidney samples of various sham-and DHT-treated mice, and RAP fingerprints were compared among animals under the same treatment. Since no differences were observed between mice of the same group (results not shown), a single animal from each situation (induced vs. control) was chosen as a representative to optimize the conditions for obtaining reproducible and differential RAP fingerprints.
Isolation of differences
Representative RAP-PCR fingerprints from the control and hormone-treated kidneys were prepared at two cDNA concentrations and run side by side on a polyacrylamide gel and compared for differences (Fig. 1B) . Only those bands that were consistently differential between DHT-and shamtreated mice at both RT concentrations were cut from the sequencing gels, reamplified, and used as probes in filters containing 3 g PolyA ϩ RNA from kidneys of sham-and DHT-treated female mice. Approximately, 60% of the selected bands proved to be differential after Northern blot analysis, when normalized with the GAPDH internal control gene.
Since each PCR product might contain more than one gene and because, in some instances, more than one transcript was found on Northern blots, bands were cloned, single colonies were selected, and individual clones were assayed again, in similar filters, by Northern blot analysis. Using this technique, up-and down-regulated products were found, as shown for clones 1-1, 2-1, and 3-1, respectively (Fig. 1C) . Sequence analysis and comparison against GenBank and dbEST databases revealed that clones 1-1, 2-1, and 3-1 correspond to the interleukin-6 signal transducer (IL-6ST), kidney androgen-regulated protein (KAP) and testosterone 16-␣-hydroxylase (16-␣ OH) genes, respectively (Table 1) .
cDNARDA
The second approach used to identify androgen-regulated genes in mouse kidney was the cDNARDA technique, which was performed in DHT-induced female kidney cDNA (tester) and sham-induced female kidney cDNA (driver).
Two successive rounds of subtraction and amplification using hybridization tester-driver ratios of 1:100 and 1:800 generated a second difference product (DP2) consisting of bands ranking from 820 -270 bp in size (Fig 2, A and B) . These bands were excised from the gel, subcloned in the BamHI site of the pBluescript II SK ϩ vector, and sequenced for further identification. A third difference product (DP3) was generated but did not identify any additional products. Eight of nine differential products from DP2 were cloned, and single colonies were selected, sequenced, and compared against GenBank and dbEST databases using the BLAST program.
As shown in Table 1 , clones 2-1 and 8 -1 were both part of the SA gene and 5-1 and 6 -1 were derived from the cytochrome CYP4B1 (CYP4B1) gene, indicating that different clones from different bands can contain contiguous DpnII fragments of the same gene. Clone 7-1 was identified as the organic anion transporter (OATP), clone 9 -1 as an endogenous murine leukemia virus (MuLV), and clone 4 -1 lacked similarity to any database sequence. The sequence was sent to theGenBank database and has been named MJAM. No obvious open reading frame was found in this sequence, and and DHT-treated female mice (DHT) was used for first-strand synthesis with oligo(dT). Second-strand cDNA synthesis was done by arbitrary priming PCR with oligo 3.99 R, using 3 and 6 l of the first-strand synthesis reaction [RT] . Arrow points to differential product 3-1 displayed in panel C of same figure. Panel C, Northern blot hybridization analysis of differential products obtained by RAP-PCR; 3 g of kidney mRNA from sham-(C) and DHTtreated (D) female mice were hybridized with random priming 32 P-labeled differential cloned products: 1-1, 2-1, and 3-1. GAPDH probe was used as an internal control gene. the six possible reading frames did not show any homology with known proteins. It is therefore possible that this fragment is derived from a noncoding portion of the gene and that other regions of the same gene may be contained in the databases. The remaining clone 3-1 was histone H1 0 and was found not to represent a genuine difference between the populations. It should be noted that a single band might contain more than one clone and that additional products may still be identified from this experiment.
Expression levels of the androgen-induced KAP gene in mouse kidney are very high, and its cDNA contains four DpnII sites. Since no clones were identified as KAP, we performed Southern hybridization analysis of difference products DP1 and DP2 with a radiolabeled KAP cDNA probe. KAP specifically hybridized to a band of 420 bp in DP2. This indicates that PCR amplification has probably favored the KAP amplicon found in this particular band and that the basal levels of expression of this gene are sufficient to compete out most of the DpnII fragments (Fig.  2C) .
We next performed Northern blot analysis to confirm that the cDNARDA difference products truly represented the expression levels seen in vivo. We found that transcripts recognized by clones 2-1, 5-1, 7-1, and 9 -1 (SA, CYP4B1, OATP, and endogenous murine leukemia virus, respectively) are strongly induced by androgens, since no mRNA expression is detected in kidneys of sham-treated females, at the exposure times studied. Clone 4 -1 (MJAM) detects two coordinately expressed androgen-inducible products that are also expressed under basal conditions (Fig. 3) .
Effects of flutamide in the expression of novel androgenregulated gene transcripts
Flutamide acts as an androgen antagonist because it binds to the androgen receptor but fails to transactivate target genes. To clearly assess the degree of control exerted by androgen on newly identified DHT-induced genes, mRNA levels were determined by Northern analysis in kidneys of C57BL/6 female mice treated with DHT and DHT plus flutamide. We observed that in the presence of flutamide, expression levels of the control ␤-GLUC gene were similar to those detected under basal conditions, indicating that the treatment was effective (Fig. 4A ). The same filters were then used to analyze the expression of target genes, and the results
FIG. 2. Androgen up-regulated difference
products identified by cDNA RDA. Panels A, B, and C, Ethidium bromide-visible bands in the 1.3% agarose gel from 820 -270 bp in size correspond to enriched target sequences after three successive rounds of subtraction/PCR process, from DHT-induced female kidney cDNA (tester) and sham-induced female kidney cDNA (driver). DP2 results from hybridization of DP1 with driver at tester-driver ratios of 1:800. DP3 results from hybridization of DP2 with driver at tester-driver ratios of 1:400.000. Size markers were derived from PBR322 plasmid digested with HinfI and included in the same gel. Panel D, Southern blot analysis of DP1 and DP2 difference products hybridized with KAP cDNA probe. clearly demonstrate flutamide sensitivity of all products, showing that all are truly and coordinately regulated by androgens (Fig. 4B) .
Expression of the newly identified androgen-regulated gene transcripts at physiological doses of androgens
We were interested in analyzing whether the induction observed at pharmacological doses of androgens would also be detectable under physiological conditions. We therefore measured the levels of androgen-regulated gene transcripts in kidneys of castrated, nontreated control, and DHT-induced castrated C57BL/6 male mice. Our results demonstrate that normal control males exhibit a clear induction of these genes in relation to the levels observed in castrated males, and that the lack of expression in castrated males can be restored by the administration of DHT (Fig. 5) . This establishes that these genes are androgen-regulated at physiological doses.
Androgen control and distribution of novel genes in mouse tissues
Expression of the SA and KAP genes is strikingly limited to the kidney (Fig. 6) ; CYP4B1 is expressed in kidney and lung; the 16␣-OH and OATP are expressed in kidney and liver; and MJAM and IL-6ST are widely distributed. Interestingly, the kidney expression of the SA and OATP genes is androgen-dependent, since only trace amounts of their mRNAs are detectable in kidneys of sham-treated female mice; a basal expression inducible by androgens is also observed for the OATP gene in liver. The CYP4B1 gene shows a nonandrogen basal expression that is inducible by androgens in kidney and lung, although induction in kidney is more prominent. The IL-6ST gene, which is expressed in every tissue tested, appears not to be regulated by androgens in tissues such as liver, brain, and cerebellum; is repressed by androgens in spleen and heart; and is androgen-induced in kidney and lung. A very interesting finding is the fact that only in kidney and under the exclusive presence of androgens, two different mRNA species appear for the IL-6ST gene, in addition to the 7-and 10-kb mRNAs that are present, at different ratios, in every tissue tested. The unknown gene identified in this study, MJAM, is also inducible by androgens in kidney and lung. Finally, while expression of the 16␣-OH gene is repressed by androgens in kidney, it appears to be up-regulated in liver. All hybridization signals have been normalized with the signal obtained for the housekeeping internal GAPDH control gene.
Discussion
By using two different subtraction systems we have been able to isolate and identify new androgen-regulated genes in mouse kidney. The coordinated use of two complementary techniques, RAP-PCR, which is able to detect subtle differences, and cDNARDA, which detects greater levels of induction, has allowed the identification of marker genes with different levels of androgen inducibility. In this study we have identified a set of genes previously not known to be under androgen control and have clearly demonstrated that they are androgen-regulated in a coordinated and reproducible fashion at both pharmacological and physiological doses.
For several years, our laboratory has been involved in the study of the regulation of the KAP gene, and a cell-specific multihormonal regulation of its expression has been reported (22, 37) . Thyroid hormone controls KAP mRNA levels in the epithelial cells of proximal tubules, specifically in the pars recta or S3 segment (23) , while androgens are responsible for expression in the pars convoluta or segments S1 and S2 of the same tubules (16) . From these studies, we have also learned that the KAP androgen-dependent cortical expression depends on the presence of thyroid hormone (24) and that estrogens further induce its expression in the S3 cells (22) .
Identification of putative common regulatory elements in the promoters of androgen-regulated genes has been troublesome. Androgenic inducibility of the KAP gene is very different from that exhibited by other classic androgenic markers of mouse kidney, and both kinetics of induction and patterns of expression vary with strain and tissue specificity. Consequently, in the absence of an appropriate androgenresponsive cell culture system, the elements responsible for the generation of an androgen-regulated phenotype in mouse kidney have been very difficult to describe. For this reason, we have undertaken a project aimed at defining multiple new markers of androgen action in mice of the same strain, exposed to identical induction conditions. In this way, we hope to be able to compare regulatory elements and pinpoint common features.
We have identified several genes as being androgen-sensitive in the mouse kidney. SA and OATP are the mouse counterparts of the human and rat SA genes and the rat OATP gene, respectively. The genes coding for CYP4B1, MuLV, 130-kDa subunit of the IL-6ST, and 16-␣-OH correspond to genes previously identified in the mouse. Our demonstration of androgen induction of the OATP gene in mouse kidney tallies with the recent report of its regulation by testosterone in rat kidney (38) . Analysis of tissue distribution and androgenic control of the genes found has allowed us to classify them as kidney-specific (SA and KAP), highly restricted (OATP, CYP4B1, and 16␣-OH), or widely expressed (IL-6ST and MJAM). Promoter analysis of these kidney-specific genes might allow further identification of enhancer sequences responsible for tissue specificity, which would prove useful in transgenic experiments.
Although SA and KAP genes share kidney specificity, they differ in their regulation. While SA is practically not expressed in the absence of androgens, KAP exhibits an important androgen-independent basal expression that increases or diminishes in the presence or absence of androgens, respectively. IL-6ST and CYP4B1 are widely expressed, but their androgen regulation appears to be restricted to the kidney. The fact that the MJAM is also regulated by androgens in lung, as are OATP and 16␣-OH genes in liver, suggests that these tissues might share common elements needed for androgenic control of expression. In instances where an androgen-independent basal expression exists, it will be necessary to define wether such expression is constitutive or, as for the KAP gene, other hormones are involved in their regulation.
The mechanisms by which androgens modulate the transcript levels of these genes is the subject of continuing research in our laboratory. Since members of the steroid/thyroid receptor superfamily can transactivate and also stabilize previously synthesized mRNAs, we are currently attempting to determine which of these genes are under androgen transcriptional control by performing run-on nuclear assays. We are also investigating whether androgen regulation of these genes is blocked by inhibitors of protein synthesis, as well as characterizing putative consensus sequences in their promoters. In this way, we hope to delineate the extent to which these genes are under direct androgen transcriptional control.
The physiological significance of androgen-inducible gene expression in the kidney is largely unknown since most of the target genes identified so far correspond to housekeeping genes and genes whose protein products have not been entirely characterized. We believe that at least three of the genes identified in this study, SA, CYP4B1, and IL6ST, may prove to be interesting from the pathophysiological perspective. The SA gene is a major component of an important system regulating blood pressure (39) . Our finding that it is under very strong androgen control might be very important for understanding the hormonal control of certain forms of hypertension in which a sexually dimorphic pattern of blood pressure has been observed (40) . We are currently trying to correlate levels of blood pressure, presence of androgens, and expression of the SA gene in kidneys of normal and hypertensive rats and mice.
The finding that expression of the CYP4B1 gene is induced by androgens in kidney is particularly interesting since Imakoa et al. (41) have reported that CYP4B1 plays a major role in the mutagenic activation of the potent procarcinogen, 3-methoxy-4-aminoazobenzene (41) . Metabolism of this and others substrates, such as 2-aminofluoreno and 2-aminoanthracene, may affect the homeostasis of the kidney and its susceptibility to disease. Lung carcinomas exhibit higher levels of CYP4B1 mRNA than normal lung tissues (42), and we (1), nontreated control (2), and DHT-induced castrated (3) C57BL/6 male mice analyzed by Northern blot analysis. Male mice were castrated under droperidol and midazolam anesthesia and allowed to recover for 8 days before any further treatment. Androgen-treated animals were treated for a period of 8 days with a DHT dose of 19 g/day and killed by cervical dislocation. mRNA (3 g) was electrophoresed in a 6.5% formaldehyde-1.4% agarose gel, blotted to nylon membranes, and hybridized with random priming 32 P-labeled cDNA probes. The GAPDH probe was used as an internal control on each hybridization.
find provocative the possible association of the androgenic up-regulation of a member of the cytochrome P450 enzyme family in kidney with the well documented higher incidence of renal cell carcinomas in man than in woman. Interestingly, the great majority of these tumors develop from epithelial cells of proximal convoluted tubules, which are, in turn, the cellular targets for androgen action.
The IL-6ST gp130, although initially described as the IL-6 signal transducer, is the signal transducer protein for receptors recognizing IL-11, leukemia inhibitory factor, ciliary neurotrophic factor, oncostatin M, and the recently described cardiotrophin-1 (43) . In relation to its tissue distribution, murine gp130 is ubiquitously expressed, and Saito et al. (44) have reported the existence of two species of mRNA (7 and 10 kb) with different ratios in each tissue examined. Our work shows the appearance of two new gp130 transcripts, exclusively in kidney and only under the presence of androgens. Although the physiological significance of our findings remains to be elucidated, it is interesting to determine whether these two new forms of gp130 also appear in androgen-exposed human kidneys and whether putative new forms of gp130 might modify the biological effects exerted by interleukin-6, which has been reported to be produced by some renal cell carcinomas and to be responsible for several paraneoplastic syndromes in the carcinoma (45) .
In summary, the complementary use of two PCR-based methods for the identification of differential gene expression (cDNARDA and RAP-PCR) has proved to be successful in the identification of androgen-regulated genes in mouse kidney. Our work has provided new models for the study of androgen action in kidney at the molecular and pathophysiological levels.
